171 results
Page 3 of 9
8-K
EX-10.1
cptrmef
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
8-K
EX-10.1
ypl4dxu
25 Sep 20
Diffusion Pharmaceuticals Strengthens Management Team with Appointmentof William Elder as General Counsel and Corporate Secretary
4:57pm
8-K
EX-10.1
v0vf5s45x
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am
8-K
EX-10.2
3qhxkfmbl7z2g727fg
9 Sep 20
Diffusion Pharmaceuticals Names Director Dr. Robert Cobuzzi as President and Chief Executive Officer
9:30am
8-K
EX-10.1
lz1pglwoobbg
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
EX-10.2
8605cc41arco rt5
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
EX-10.1
7ics6 qq0wy70n1mq
8 May 20
Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
4:40pm
8-K
EX-10.1
kpixeeb0
18 Mar 20
Diffusion Pharmaceuticals Announces Retirement of Chief Science Officer John L. Gainer
5:22pm
8-K
EX-10.2
h097e0c3 7a1dx5y7
18 Mar 20
Diffusion Pharmaceuticals Announces Retirement of Chief Science Officer John L. Gainer
5:22pm
8-K
EX-10.1
0ummrt32u1 7p5hp62
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-10.2
w0i1ftrpq3 j0
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-10.2
1ua14wa 5slo6a7cg
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-10.1
werww98
28 May 19
Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement
4:44pm
8-K
EX-10.2
3ej5915s zqc2th0s
28 May 19
Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement
4:44pm
8-K
EX-10.2
7o0b6i
27 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
ulkrmsq
27 Sep 18
Entry into a Material Definitive Agreement
12:00am